The initiation of the Cerba Research and Viroclinics-DDL “Virus Biobank” operation looks to be highly promising for advancements in epidemiology research. This recent project, focusing on processing and storing respiratory viruses, will greatly benefit current research, diagnosis, prevention, and treatment of viruses like SARS-CoV-2, Influenza virus A/B and Respiratory Syncytial Virus (RSV).
Biobanks have made monumental contributions to healthcare, biotechnology, disease control and prevention, along with bio-conservation. They represent an essential tool for the development of disease diagnosis, prevention and treatment. In light of recent virus outbreaks, the most devastating example being COVID-19, the need for virus biobanks for pathology research is becoming increasingly apparent.
Case Study – Cerba Research Virus Biobank
Reach out to our experts and discover how we can help you transform research and advance healthcare.Contact Us